Autifony Therapeutics
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Autifony Therapeutics has raised €10M across 2 funding rounds, most recently a round in Jun 2014. Based in London, UK; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€10M
€10,008,000
Funding rounds
2
Investors
0
distinct backers
Active since
2011-08
latest 2014-06
Funding by year
EUR raised per yearAutifony Therapeutics — funding by year — interactive chart.
Data table
| Autifony Therapeutics — funding by year | |
|---|---|
| 2011 | €7.0M |
| 2014 | €3.1M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-06-01 | Other | €3.1M | — | View deal → |
| 2011-08-01 | Other | €7.0M | — | View deal → |